A detailed history of Cibc Private Wealth Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 9,294,783 shares of AZN stock, worth $725 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
9,294,783
Previous 10,424,914 10.84%
Holding current value
$725 Million
Previous $702 Million 10.31%
% of portfolio
1.26%
Previous 1.51%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$61.03 - $69.57 $69 Million - $78.6 Million
-1,130,131 Reduced 10.84%
9,294,783 $630 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $55 Million - $61.6 Million
889,178 Added 9.32%
10,424,914 $702 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $28.4 Million - $31.4 Million
-438,164 Reduced 4.39%
9,535,736 $646 Million
Q2 2023

Nov 21, 2023

BUY
$69.91 - $75.81 $30.6 Million - $33.2 Million
438,164 Added 4.59%
9,973,900 $714 Million
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $4.42 Million - $4.79 Million
63,209 Added 0.64%
9,973,900 $714 Million
Q1 2023

Nov 21, 2023

BUY
$63.15 - $71.6 $23.7 Million - $26.8 Million
374,955 Added 3.93%
9,910,691 $688 Million
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $54.1 Million - $61.4 Million
-856,904 Reduced 7.96%
9,910,691 $688 Million
Q4 2022

Jun 01, 2023

BUY
$54.21 - $70.44 $46.5 Million - $60.4 Million
857,717 Added 8.65%
10,768,408 $730 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $2.51 Million - $3.26 Million
-46,345 Reduced 0.43%
10,767,595 $730 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $4.41 Million - $11.3 Million
83,177 Added 0.78%
10,813,940 $593 Million
Q2 2022

Aug 03, 2022

BUY
$59.26 - $71.14 $88.3 Million - $106 Million
1,490,165 Added 16.13%
10,730,763 $709 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $69.6 Million - $83.8 Million
1,248,900 Added 15.63%
9,240,598 $613 Million
Q4 2021

Feb 08, 2022

BUY
$54.02 - $63.83 $34.2 Million - $40.5 Million
633,767 Added 8.61%
7,991,698 $466 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $38.8 Million - $42.4 Million
697,507 Added 10.47%
7,357,931 $442 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $11.8 Million - $14.7 Million
243,614 Added 3.8%
6,660,424 $399 Million
Q1 2021

May 12, 2021

BUY
$47.16 - $54.44 $79.8 Million - $92.2 Million
1,693,064 Added 35.84%
6,416,810 $319 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $45.8 Million - $54.7 Million
942,954 Added 24.94%
4,723,746 $236 Million
Q3 2020

Nov 03, 2020

BUY
$53.07 - $61.1 $201 Million - $231 Million
3,780,792 New
3,780,792 $207 Million
Q3 2020

Oct 29, 2020

SELL
$53.07 - $61.1 $815,526 - $938,923
-15,367 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $26.2 Million - $33.7 Million
-608,888 Reduced 97.54%
15,367 $813,000
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $218,199 - $296,379
-5,774 Reduced 0.92%
624,255 $27.9 Million
Q4 2019

Jan 30, 2020

BUY
$42.46 - $50.46 $398,699 - $473,819
9,390 Added 1.51%
630,029 $31.4 Million
Q3 2019

Oct 16, 2019

BUY
$40.12 - $45.47 $53,479 - $60,611
1,333 Added 0.22%
620,639 $27.7 Million
Q2 2019

Jul 31, 2019

SELL
$37.28 - $41.68 $1.22 Million - $1.37 Million
-32,834 Reduced 5.03%
619,306 $25.6 Million
Q1 2019

May 10, 2019

SELL
$35.49 - $43.02 $20.6 Million - $24.9 Million
-579,250 Reduced 47.04%
652,140 $26.4 Million
Q4 2018

Feb 05, 2019

BUY
$36.86 - $41.49 $29.7 Million - $33.4 Million
805,985 Added 189.46%
1,231,390 $46.8 Million
Q3 2018

Nov 14, 2018

BUY
$34.76 - $39.72 $14.7 Million - $16.8 Million
422,557 Added 14836.97%
425,405 $16.8 Million
Q2 2018

Aug 02, 2018

BUY
$34.55 - $37.05 $19,313 - $20,710
559 Added 24.42%
2,848 $100,000
Q1 2018

May 17, 2018

SELL
$32.97 - $36.63 $305,994 - $339,963
-9,281 Reduced 80.22%
2,289 $80,000
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $371,281 - $402,404
11,570
11,570 $402,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.